Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Naomaili Granules for acute ischemic stroke
ChiCTR2000033619Phase 4Completed
- Sponsor
- Peking University Third Hospital
- Start
- Jun 2020
- Countries
- 1
01
Overview
Phase 4, randomised, double-blind trial of naomaili in ischemic stroke (2 arms), sponsored by Peking University Third Hospital. Primary endpoints: Modified Rankin Scale and Incidence of cardiovascular and cerebrovascular events. Started Jun 2020; status: completed.
02
Drugs
naomaili
03
Conditions
ischemic stroke
Beyond the preview
Go deeper on ChiCTR2000033619.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR2000033619.